PH27278A - Spiro-isoquinoline-pyrrolidine tetrones useful as aldose reductase inhibitors - Google Patents
Spiro-isoquinoline-pyrrolidine tetrones useful as aldose reductase inhibitorsInfo
- Publication number
- PH27278A PH27278A PH39372A PH39372A PH27278A PH 27278 A PH27278 A PH 27278A PH 39372 A PH39372 A PH 39372A PH 39372 A PH39372 A PH 39372A PH 27278 A PH27278 A PH 27278A
- Authority
- PH
- Philippines
- Prior art keywords
- isoquinoline
- spiro
- useful
- reductase inhibitors
- aldose reductase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26043488A | 1988-10-20 | 1988-10-20 | |
US07/357,563 US4927831A (en) | 1988-10-20 | 1989-05-26 | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
PH27278A true PH27278A (en) | 1993-05-04 |
Family
ID=26947989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH39372A PH27278A (en) | 1988-10-20 | 1989-10-17 | Spiro-isoquinoline-pyrrolidine tetrones useful as aldose reductase inhibitors |
Country Status (9)
Country | Link |
---|---|
US (1) | US4927831A (da) |
JP (1) | JP2888559B2 (da) |
KR (1) | KR0143998B1 (da) |
CA (1) | CA1337351C (da) |
DK (1) | DK170702B1 (da) |
HU (1) | HU206211B (da) |
IL (1) | IL92054A (da) |
PH (1) | PH27278A (da) |
PT (1) | PT92025B (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5428066A (en) * | 1989-03-08 | 1995-06-27 | Larner; Joseph | Method of reducing elevated blood sugar in humans |
US5045544A (en) * | 1990-05-21 | 1991-09-03 | American Home Products Corporation | N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
US5093496A (en) * | 1990-05-21 | 1992-03-03 | American Home Products Corporation | Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
US5037831A (en) * | 1990-05-21 | 1991-08-06 | American Home Products Corporation | Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
US5068332A (en) * | 1990-10-12 | 1991-11-26 | American Home Products Corporation | Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors |
US5081241A (en) * | 1990-10-11 | 1992-01-14 | American Home Products Corporation | Spiro-pyridazines and analogs thereof useful as aldose reductase inhibitors |
US5102886A (en) * | 1990-10-12 | 1992-04-07 | American Home Products Corporation | 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors |
US5130425A (en) * | 1990-10-12 | 1992-07-14 | American Home Products Corporation | Spiro-lactams and analogs thereof useful as aldose reductase inhibitors |
US5169948A (en) * | 1991-05-22 | 1992-12-08 | American Home Products Corporation | Process and intermediates for the preparation of spiro[isoquinoline-4(1H),3-pyrrolidine]1,2,3,5 (2H)-tetrones which are useful as aldose reductase inhibitors |
US5106978A (en) * | 1991-05-22 | 1992-04-21 | American Home Products Corporation | Process and intermediates for the preparation of spiro(isoquinoline-4(1H), 3'-pyrrolidine)-1,2', 3,5'(2H)-tetrones which are useful as aldose reductase inhibitors |
US6384013B1 (en) | 1992-03-19 | 2002-05-07 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
US6743777B1 (en) * | 1992-03-19 | 2004-06-01 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
US5221686A (en) * | 1992-08-04 | 1993-06-22 | American Home Products Corporation | Spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides as antihyperglycemic agents |
EP1582204B1 (en) * | 1999-03-03 | 2013-09-25 | Eli Lilly & Company | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
CA2362016A1 (en) | 1999-03-03 | 2000-09-08 | Kenneth Philip Moder | Echinocandin/carbohydrate complexes |
US6991800B2 (en) * | 2002-06-13 | 2006-01-31 | Vicuron Pharmaceuticals Inc. | Antifungal parenteral products |
US6777048B2 (en) | 2002-12-18 | 2004-08-17 | Eastman Chemical Company | Polyester compositions containing silicon carbide |
WO2005025558A1 (en) * | 2003-09-12 | 2005-03-24 | Applied Reserach Systems Ars Holding N.V. | Sulfonamide derivatives for the treatment of diabetes |
CA2534314C (en) * | 2003-09-12 | 2012-11-13 | Applied Research Systems Ars Holding N.V. | Benzothiazole derivatives for the treatment of diabetes |
WO2005097773A1 (en) * | 2004-04-07 | 2005-10-20 | Applied Research Systems Ars Holding N.V. | 1,1’-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors |
EP1778275A2 (en) * | 2004-08-12 | 2007-05-02 | Wyeth | Combination therapy for diabetes, obesity, and cardiovascular diseases using gdf-8 inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5241586U (da) * | 1975-09-18 | 1977-03-24 | ||
JPS5241587U (da) * | 1975-09-18 | 1977-03-24 | ||
FR2525603A1 (fr) * | 1982-04-27 | 1983-10-28 | Adir | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
FR2544317B2 (fr) * | 1983-04-12 | 1985-07-05 | Adir | Benzoazacycloalkyl-spiro-imidazolidines et les compositions pharmaceutiques les contenant |
-
1989
- 1989-05-26 US US07/357,563 patent/US4927831A/en not_active Expired - Lifetime
- 1989-09-27 CA CA000613705A patent/CA1337351C/en not_active Expired - Fee Related
- 1989-10-17 HU HU895335A patent/HU206211B/hu not_active IP Right Cessation
- 1989-10-17 PH PH39372A patent/PH27278A/en unknown
- 1989-10-17 JP JP1271423A patent/JP2888559B2/ja not_active Expired - Fee Related
- 1989-10-18 PT PT92025A patent/PT92025B/pt not_active IP Right Cessation
- 1989-10-19 IL IL9205489A patent/IL92054A/en not_active IP Right Cessation
- 1989-10-19 DK DK519189A patent/DK170702B1/da active IP Right Grant
- 1989-10-19 KR KR1019890015023A patent/KR0143998B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HU895335D0 (en) | 1990-01-28 |
PT92025A (pt) | 1990-04-30 |
PT92025B (pt) | 1995-07-18 |
HU206211B (en) | 1992-09-28 |
CA1337351C (en) | 1995-10-17 |
IL92054A (en) | 1994-07-31 |
JPH02164880A (ja) | 1990-06-25 |
DK519189D0 (da) | 1989-10-19 |
KR0143998B1 (ko) | 1998-07-15 |
HUT52775A (en) | 1990-08-28 |
DK519189A (da) | 1990-04-21 |
KR900006334A (ko) | 1990-05-07 |
IL92054A0 (en) | 1990-07-12 |
JP2888559B2 (ja) | 1999-05-10 |
US4927831A (en) | 1990-05-22 |
DK170702B1 (da) | 1995-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH27278A (en) | Spiro-isoquinoline-pyrrolidine tetrones useful as aldose reductase inhibitors | |
JPS6426535A (en) | Novel hmg-coa reductase inhibitor | |
AU8582591A (en) | Multifunctional scale inhibitors | |
GR862006B (en) | Novel hmg-coa reductase inhibitors | |
AU3580189A (en) | Novel glucosidase inhibitors | |
EP0251625A3 (en) | Novel hmg-coa reductase inhibitors | |
AU3464889A (en) | Novel polyanhydrides | |
EP0403487A4 (en) | Novel hmg-coa reductase inhibitors | |
AU613302B2 (en) | Quinolyloxazole-2-ones useful as proteinkinase c inhibitors | |
GB2224734B (en) | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors | |
EP0323866A3 (en) | Novel hmg-coa reductase inhibitors | |
ZA886468B (en) | Novel hmg-coa reductase inhibitors | |
JPS6463595A (en) | Ribonucleotide reductase inhibitor | |
AU6593090A (en) | Novel pyridyloxyazole-2-ones useful as proteinkinase c inhibitors | |
GB2188047B (en) | Aldose reductase inhibitor | |
AU3298389A (en) | Hammer for pile-drivers | |
EP0306263A3 (en) | Novel hmg-coa reductase inhibitors | |
ZA897929B (en) | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors | |
IE861411L (en) | Spiro-imidazolidines as aldose reductase inhibitors | |
ZA851426B (en) | 17 beta-n-monosubstituted carbamoyl-4-aza-5 alpha-androst-1-en-3-ones as 5 alpha reductase inhibitors | |
GB9303051D0 (en) | 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors | |
ZA874487B (en) | Novel hmg-coa reductase inhibitors | |
EP0468974A4 (en) | Novel hmg-coa reductase inhibitors | |
IE870041L (en) | Heterocyclic aldose reductase inhibitors | |
IE882652L (en) | NOVEL HMG-CoA REDUCTASE INHIBITORS |